Listed

Veracyte, Inc.

VCYTNasdaqCIK 1384101HealthcareFiscal year ends Dec 31

Reports and events: 225 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Veracyte, Inc., Reports and events
FiledFormWhat it isAccession number
2026-09-1416:07 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001384101-26-000049
2026-07-3116:11 ET10-QQuarterly reportPeriod 2026-06-300001384101-26-000044
2026-07-3016:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001384101-26-000042
2026-06-1116:32 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001384101-26-000038
2026-05-0608:07 ET10-QQuarterly reportPeriod 2026-03-310001384101-26-000031
2026-05-0516:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001384101-26-000029
2026-04-2216:06 ETDEF 14AProxy statementPeriod 2026-06-100001384101-26-000021
2026-03-1616:17 ET8-K5.02 Departure or appointment of officers or directors0001384101-26-000012
2026-02-2616:32 ET10-KAnnual reportPeriod 2025-12-310001384101-26-000010
2026-02-2516:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001384101-26-000008
2026-01-1206:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001384101-26-000002
2025-11-0508:15 ET10-QQuarterly reportPeriod 2025-09-300001384101-25-000130
2025-11-0416:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001384101-25-000128
2025-08-0716:41 ET10-QQuarterly reportPeriod 2025-06-300001384101-25-000110
2025-08-0616:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001384101-25-000106
2025-06-1816:46 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001384101-25-000083
2025-05-0808:06 ET10-QQuarterly reportPeriod 2025-03-310001384101-25-000060
2025-05-0716:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001384101-25-000058
2025-04-2916:34 ETDEF 14AProxy statementPeriod 2025-06-170001384101-25-000051
2025-02-2821:58 ET10-KAnnual reportPeriod 2024-12-310001384101-25-000014
2025-02-2416:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001384101-25-000010
2024-11-0708:01 ET10-QQuarterly reportPeriod 2024-09-300001384101-24-000162
2024-11-0616:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001384101-24-000160
2024-09-0416:10 ET8-K5.02 Departure or appointment of officers or directors0001384101-24-000133
2024-08-0708:11 ET10-QQuarterly reportPeriod 2024-06-300001384101-24-000118
2024-08-0616:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001384101-24-000116
2024-06-1316:27 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001384101-24-000093
2024-05-0817:03 ET10-QQuarterly reportPeriod 2024-03-310001384101-24-000067
2024-05-0716:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001384101-24-000064
2024-04-2516:34 ETDEF 14AProxy statementPeriod 2024-06-120001384101-24-000057
2024-04-1716:34 ET8-K/A9.01 Financial statements and exhibits0001384101-24-000051
2024-03-2216:49 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-075385
2024-02-2917:27 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-053689
2024-02-2908:06 ET10-KAnnual reportPeriod 2023-12-310001384101-24-000017
2024-02-2216:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001384101-24-000013
2024-02-1316:15 ET8-K5.02 Departure or appointment of officers or directors0001384101-24-000007
2024-02-0608:23 ET8-K2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity0001384101-24-000004
2024-01-0808:12 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-24-003949
2023-11-0808:30 ET10-QQuarterly reportPeriod 2023-09-300001384101-23-000163
2023-11-0716:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001384101-23-000161
2023-08-0916:07 ET10-QQuarterly reportPeriod 2023-06-300001384101-23-000142
2023-08-0816:11 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001384101-23-000140
2023-06-0917:01 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results0001384101-23-000112
2023-05-0508:07 ET10-QQuarterly reportPeriod 2023-03-310001384101-23-000067
2023-05-0416:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001384101-23-000065
2023-04-2716:32 ETDEF 14AProxy statement0001384101-23-000055
2023-03-0117:48 ET10-KAnnual reportPeriod 2022-12-310001384101-23-000016
2023-02-2216:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001384101-23-000011
2023-02-1016:44 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001384101-23-000007
2022-12-1408:25 ET8-K5.02 Departure or appointment of officers or directors0001384101-22-000162

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.